AstraZeneca Resumes Coronavirus Vaccine Trials

Trials of the Covid-19 coronavirus disease drug produced by AstraZeneca, which were carried out at the University of Oxford, were stopped on September 6 due to a side effect in one of the volunteers. However, on September 12, clinical studies were resumed.

The press service of the pharmaceutical company reports on this.

The decision was reportedly made after the UK Medicines and Healthcare Products Administration (MHRA) confirmed the safety of the tests.

At the same time, the company has not yet specified what side effects were seen in a volunteer who experienced the vaccine on himself. However, according to journalists, he was diagnosed with transverse myelitis, an inflammatory disease of the bone marrow, which usually occurs due to the presence of a virus in the body.

It should be noted that at this time AstraZeneca, Pfizer and Moderna have reached the third phase of trials of the Covid-19 vaccine in the United States.

Meanwhile, in Russia, the first batch of the Sputnik V Covid-19 vaccine has already entered civil circulation. In turn, the Ukrainian authorities decided not to buy the Russian drug, but to wait until its analog is produced in the EU and the United States.

Earlier we wrote that, according to the adviser to the head of the Russian Ministry of Health Sergei Glagolev, a document on vaccination against the coronavirus will soon be mandatory for international flights and travel.